Article info
Unexpected outcome (positive or negative) including adverse drug reactions
Long-term survival of a patient with carcinomatous meningitis due to non-small cell lung cancer treated with erlotinib following gefitinib
- Correspondence to Dr Tomoyoshi Takenaka, ttake{at}surg2.med.kyushu-u.ac.jp
Citation
Long-term survival of a patient with carcinomatous meningitis due to non-small cell lung cancer treated with erlotinib following gefitinib
Publication history
- First published September 15, 2011.
Online issue publication
August 07, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2011 BMJ Publishing Group Ltd